Spots Global Cancer Trial Database for idecabtagene vicleucel
Every month we try and update this database with for idecabtagene vicleucel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Secondary Malignancy | NCT06357754 | Non-Hodgkin Lym... Chronic Lymphoc... Multiple Myelom... | Idecabtagene vi... Lisocabtagene m... | - | Bristol-Myers Squibb | |
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation | NCT06045806 | Multiple Myelom... | idecabtagene vi... Lenalidomide Fludarabine Cyclophosphamid... | 18 Years - | Celgene | |
Expanded Access Protocol (EAP) for Participants Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release | NCT04771078 | Multiple Myelom... | Nonconforming i... | 18 Years - | Celgene | |
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation | NCT06045806 | Multiple Myelom... | idecabtagene vi... Lenalidomide Fludarabine Cyclophosphamid... | 18 Years - | Celgene |